Literature DB >> 31547944

The impact of target dosimetry on patients' locoregional recurrence in nasopharyngeal carcinoma: A propensity score-matched analysis.

Jiazhou Wang1, Gan Qing1, Xiaomin Ou1, Weigang Hu1, Chaosu Hu2, Zhen Zhang3.   

Abstract

PURPOSE: To analyze the impact of target dosimetry using propensity score matching (PSM) on patients' locoregional recurrence for nasopharyngeal carcinoma (NPC) and to find significant dose-volume factors of recurrence.
METHODS: Sixty-eight nasopharyngeal carcinoma (NPC) patients with recorded locoregional recurrence were enrolled in this study. These patients were treated with IMRT in 2009-2010 in our department. Another 198 NPC patients without recurrence were randomly selected from the same treatment time period. The median follow-up time for all patients was 49.0 months. PSM was performed to match the recurrence and nonrecurrence cohorts. Dose-volume histograms (DVHs) of treatment planning were extracted for statistical analysis. Cox hazard model and Kaplan-Meier log-rank analysis were performed to evaluate correlations between PTV dose coverage and local/region recurrence.
RESULTS: Propensity score matching balanced the clinical factors in two matches. Univariate cox survival model showed D90 and D95 were significantly correlated to the recurrence, and the D90 was the most significant (p = 0.036) one. The results of multivariate analysis show that only D90 is required for recurrence prediction when collinear dosimetric factors are considered. KM log-rank analysis showed that patients have significant local/regional control differences (p-value = 0.036, log-rank) in the D90 >101% and D90 <101% groups.
CONCLUSION: D90 corresponds to significant dose-volume factors. PTV dose coverage has a significant impact on locoregional recurrence in NPC clinical routine patients.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dose–volume factors; Locoregional recurrence; NPC; Propensity score-matched

Mesh:

Year:  2019        PMID: 31547944     DOI: 10.1016/j.radonc.2019.09.001

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  3 in total

1.  Long-term outcomes of nasopharyngeal carcinoma patients with T1-2 stage in intensity-modulated radiotherapy era.

Authors:  Xiaoshuang Niu; Fen Xue; Peiyao Liu; Chaosu Hu; Xiayun He
Journal:  Int J Med Sci       Date:  2022-01-01       Impact factor: 3.738

2.  A novel dosimetric metrics-based risk model to predict local recurrence in nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy.

Authors:  Wenjun Liao; Jinlan He; Zijian Liu; Maolang Tian; Jiangping Yang; Jiaqi Han; Jianghong Xiao
Journal:  Radiat Oncol       Date:  2021-09-23       Impact factor: 3.481

3.  The dosimetric impact of deep learning-based auto-segmentation of organs at risk on nasopharyngeal and rectal cancer.

Authors:  Hongbo Guo; Jiazhou Wang; Xiang Xia; Yang Zhong; Jiayuan Peng; Zhen Zhang; Weigang Hu
Journal:  Radiat Oncol       Date:  2021-06-23       Impact factor: 3.481

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.